143 Episodo

  1. Angiosarcoma Essentials

    Publicado: 18/12/2024
  2. The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

    Publicado: 12/12/2024
  3. Women’s Health Frontiers: Breakthroughs from ESMO 2024

    Publicado: 28/11/2024
  4. ESMO Congress Prostate Cancer Highlights

    Publicado: 14/11/2024
  5. How to interpret prognostic models papers in hematology and oncology

    Publicado: 31/10/2024
  6. Stage III Lung Cancer Resecability

    Publicado: 17/10/2024
  7. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

    Publicado: 3/10/2024
  8. Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)

    Publicado: 19/9/2024
  9. Fear of recurrence: one of the major elements in reactivating cancer

    Publicado: 25/7/2024
  10. Immunohistochemistry in oncology

    Publicado: 11/7/2024
  11. Thrombosis and cachexia in cancer: Two partners in crime?

    Publicado: 13/6/2024
  12. From clinical and academic culture in radiation oncology - how to cross the chasm?

    Publicado: 30/5/2024
  13. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Publicado: 16/5/2024
  14. Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Publicado: 30/4/2024
  15. Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Publicado: 18/4/2024
  16. The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    Publicado: 4/4/2024
  17. Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Publicado: 20/3/2024
  18. An inter-specialty cancer training programme curriculum for Europe

    Publicado: 7/3/2024
  19. Communicating the oncological diagnosis: a psycho-oncological perspective

    Publicado: 22/2/2024
  20. ESMO 2023 Highlights on lung cancer

    Publicado: 8/2/2024

1 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site